Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
It’s unclear what will happen to a large number of tax credits and deductions that were included in the first release of OMB instructions.

Trump funding freeze flounders, ICC sanctions bill stalled

The Office of Management and Budget’s funding freeze was scheduled to go into effect at 5 p.m. today. And a federal judge has already temporarily blocked it.

Biden-appointed Judge Loren AliKhan of the U.S. District Court for the District of Columbia stopped the freeze just minutes before it was set to begin, the Associated Press reported. The administrative stay will last until Monday.

Subscripion logo

You're seeing a preview of our Premium coverage. Read the full story by subscribing here.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.